SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001013762-23-007274
Filing Date
2023-10-27
Accepted
2023-10-27 16:04:38
Documents
6
Period of Report
2023-12-19

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT def14a1023_inmedpharma.htm DEF 14A 1573687
2 GRAPHIC tinmed_logo.jpg GRAPHIC 114164
3 GRAPHIC tkpmg_logo.jpg GRAPHIC 30766
4 GRAPHIC tkpmg_sign.jpg GRAPHIC 21846
5 GRAPHIC tproxy_001.jpg GRAPHIC 952382
6 GRAPHIC tproxy_002.jpg GRAPHIC 1253082
  Complete submission text file 0001013762-23-007274.txt   4842935
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-39685 | Film No.: 231355504
SIC: 2834 Pharmaceutical Preparations